Efficacy and safety of vena cava filters in preventing pulmonary embolism: A systematic review and meta-analysis

Abstract

Objectives

To assess the treatment effectiveness of inferior vena cava filters (IVCF) versus non-IVCF for patients undergoing varies conditions.

Methods

We systematically searched the databases to identify eligible RCTs from their inception up to 9/20/2020. The primary endpoint was pulmonary embolism (PE), while the secondary endpoints included deep-vein thrombosis (DVT), major bleeding, and all-cause mortality. The RRs with 95% CIs were applied as effect estimates for the treatment effectiveness of IVCF versus non-IVCF and calculated by using the random-effects model.

Results

1,137 patients of 5 RCTs were enrolled. There were no significant differences between IVCF and non-IVCF for the risk of PE, major bleeding, and all-cause mortality, while the risk of DVT was significantly increased for patients treated with IVCF.

Conclusions

The use of IVCF did not yield any benefits on PE, major bleeding, and all-cause mortality risk for patients undergoing various conditions, while the risk of DVT was significantly increased for patients treated with IVCF.

Keywords

Acute venous thromboembolism inferior vena cava filters deep-vein thrombosis major bleeding pulmonary embolism

Get full access to this article

View all access options for this article.

References

Kahn

Houweling

Granton

, et al. Long-term outcomes after pulmonary embolism: current knowledge and future research. Blood Coagul Fibrinolysis 2014; 25: 407–415.

Park

Messina

Dargon

, et al. Recent trends in clinical outcomes and resource utilization for pulmonary embolism in the United States: findings from the nationwide inpatient sample. Chest 2009; 136: 983–990.

American College of Radiology, Society of Interventional Radiology and Society for Pediatric Radiology . ACR-SIR-SPR practice parameter for the performance of inferior vena cava (IVC) filter placement for the prevention of pulmonary embolism. Virginia: American College of Radiology, 2016. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/ivc-fliterplacement.pdf.

Angel

Tapson

Galgon

, et al. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol 2011; 22: 1522–1530.

Dasta

Pilon

Mody

, et al. Daily hospitalization costs in patients with deep vein thrombosis or pulmonary embolism treated with anticoagulant therapy. Thromb Res 2015; 135: 303–310.

Heit

Spencer

White

. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016; 41: 3–14.

Goldhaber

. Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol 2012; 25: 235–242.

Kearon

Akl

Comerota

, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S–e496S.

Hann

Streiff

. The role of vena caval filters in the management of venous thromboembolism. Blood Rev 2005; 19: 179–202.

10.

Prepic Study Group . Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112: 416–422.

11.

Decousus

Leizorovicz

Parent

, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 1998; 338: 409–415.

12.

Rajasekhar

Lottenberg

, et al. A pilot study on the randomization of inferior vena cava filter placement for venous thromboembolism prophylaxis in high-risk trauma patients. J Trauma 2011; 71: 323–328. ; discussion 328-329.

13.

Barginear

Gralla

Bradley

, et al. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. Support Care Cancer 2012; 20: 2865–2872.

14.

Mismetti

Laporte

Pellerin

, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. Jama 2015; 313: 1627–1635.

15.

Rao

Honeybul

, et al. A multicenter trial of vena cava filters in severely injured patients. N Engl J Med 2019; 381: 328–337.

16.

Moher

Liberati

Tetzlaff

, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.

17.

Jadad

Moore

Carroll

, et al.

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Control Clin Trials 1996; 17: 1–12.

18.

DerSimonian

Laird

. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.

19.

Ades

Higgins

. The interpretation of random-effects meta-analysis in decision models. Med Decis Making 2005; 25: 646–654.

20.

Deeks

Higgins

Altman

. Analysing data and undertaking meta‐analyses. Cochrane handbook for systematic reviews of interventions. Hoboken, NJ: John Wiley & Sons, 2019.

21.

Higgins

Thompson

Deeks

, et al. Measuring inconsistency in meta-analyses. Bmj 2003; 327: 557–560.

22.

Tobias

. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 47: 15–17.

23.

Altman

Bland

. Interaction revisited: the difference between two estimates. Bmj 2003; 326: 219.

24.

Egger

Davey Smith

Schneider

, et al. Bias in meta-analysis detected by a simple, graphical test. Bmj 1997; 315: 629–634.

25.

Begg

Mazumdar

. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088–1101.

26.

Jiang

Jiao

Zhang

. The short-term efficacy of vena cava filters for the prevention of pulmonary embolism in patients with venous thromboembolism receiving anticoagulation: Meta-analysis of randomized controlled trials. Phlebology 2017; 32: 620–627.

27.

Yunes

Aizman

. Is it worth adding an inferior vena cava filter to anticoagulation in thromboembolic disease? Medwave 2017; 17: e6935.

28.

Rojas-Hernandez

Zapata-Copete

García-Perdomo

. Role of vena cava filters for the management of cancer-related venous thromboembolism: systematic review and meta-analysis. Crit Rev Oncol Hematol 2018; 130: 44–50.

29.

Ahmed

Paul

, et al. Meta-analysis of the usefulness of inferior vena cava filters in massive and submassive pulmonary embolism. Am J Cardiol 2020; 128: 54–59.

30.

Montgomery

Kaufman

. Inferior vena cava filters: indications, outcomes, and evidence. Curr Treat Options Cardiovasc Med 2015; 17: 401.

31.

Caplin

Nikolic

Kalva

, et al. Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol 2011; 22: 1499–1506.

32.

Becker

Philbrick

Selby

. Inferior vena cava filters. Indications, safety, effectiveness. Arch Intern Med 1992; 152: 1985–1994.

33.

Tardy

Mismetti

Page

, et a. Symptomatic inferior vena cava filter thrombosis: clinical study of 30 consecutive cases. Eur Respir J 1996; 9: 2012–2016.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.68 MB